Abstract. A monoclonal antibody (MAb)-based latex agglutination (MAb-LA) test was developed to rapidly identify Burkholderia pseudomallei in hemoculture of patients with septicemic melioidosis. The method was evaluated in a clinical situation on 396 hemocultures positive for bacterial growth, of which 75 cultures were positive for B. pseudomallei by conventional biochemical tests. The sensitivity and specificity of the MAb-LA test were 95% and 100%, respectively. The positive and negative predictive values were 100% and 99%. The method is highly reliable and suitable for rapid diagnosis of septicemic melioidosis, reducing the time normally required from a minimum of 3-4 days by conventional methods to less than 30 hr. Most of these 30 hr are involved in growing up enough bacteria to perform the MAb-LA test, which itself takes only 1 min.
Melioidosis, an infectious disease caused by Burkholderia pseudomallei, remains an important public health problem in the endemic Southeast Asian countries and northern Australia. Identification of the causative agent by conventional bacterial culture and biochemical tests is still used as gold standard for definitive diagnosis. 1, 2 However, misidentification of B. pseudomallei using the API 20NE tests (BioMerieux, Marcy l'Etoile, France) has been noted. 3 Generally, it takes at least 3-4 days before the result is obtained and by that time it may be too late for acutely ill septicemic patients. 4, 5 To speed up the diagnosis, several methods based on immunologic and molecular approaches have been developed, but most of them have never been critically evaluated in an actual clinical situation. 4 Antibody detection assays are not very useful, particularly in the endemic areas where subclinical infection exists. [6] [7] [8] In our hands, the detection of IgM antibody does not give results any better than the detection of IgG antibody. 7 Thus, antigen detection assays have been developed, but the limited data currently available suggest that further refinement is needed. [9] [10] [11] [12] Using a specially designed ELISA system, Desakorn and others were able to detect antigen in the urine in 80% of patients with culture-proven melioidosis. 10 A few years ago, we produced monoclonal antibodies (MAbs) that could agglutinate specifically only with the B. pseudomallei isolates of the arabinose-negative biotype. 8, 13 One of these MAbs was used for antigen detection, but the sensitivity of the method was only 75%. 9 A molecular approach using DNA hybridization and the polymerase chain reaction has been reported with satisfactory results in laboratory tests, but in the most recent communication, the results from a clinical setting were rather disappointing, particularly with regard to sensitivity, which was reported to be only 67%. 14 The main objective for the present study was to compare the MAb-based latex agglutination test (MAb-LA) in actual clinical settings with the conventional biochemical test for the identification of B. pseudomallei in hemoculture fluid.
The method described herein was based on the use of MAbs previously shown to be reactive with a 200-kD surface antigen present only in the arabinose-negative B. pseudomallei. One such antibody (5F8) is an IgM antibody and has already been described in detail. 8, 13 The other 2 MAbs, 4B11 (IgG 3 ) and 6G9 (IgG 2a ), reacted with different epitopes on the 200-kD component (Sirisinha S, unpublished data). All 3 MAbs did not react in the ELISA and immunoblot analyses with crude extracts or with purified lipopolysaccharide prepared from other gram-negative bacteria or with purified B. pseudomallei capsular polysaccharide CP-1a, CP1b, and CP-2 (kindly provided by Dr. K. Kawahara, Department of Bacteriology, Kitasato Institute, Tokyo, Japan). 15 Competitive ELISA analysis using the IgG1 MAb 3015, which reacted with high molecular weight exopolysaccharide (kindly provided by Dr. I. Steinmetz, Institute of Medical Microbiology, Hannover Medical School, Hannover, Germany), 16 showed that our MAbs most probably react with different epitopes present on the same high molecular weight component (Anuntagool N, unpublished data). The MAb mixture consisting of 5F8, 4B11, and 6G9 at a ratio of 1:2: 2 by weight was used for the sensitization of latex particles (0.81-m diameter; Interfacial Dynamics Corporation, Portland, OR). The sensitized latex particle suspension reacted positively with more than 100 human, animal, and environmental B. pseudomallei strains of the arabinose-negative biotype from Thailand, Malaysia, Singapore, Cambodia, Laos, and Hong Kong. 13 It did not react with 70 arabinose-positive environmental B. pseudomallei and 13 other gram-negative and 4 gram-positive bacteria relevant in clinical situations. The reagent is stable for more than 1 year when kept at 4ЊC.
Blood specimens were collected from patients admitted to 2 provincial hospitals in the area of Thailand endemic for melioidosis during May and October 1998. These specimens were subjected to routine hemoculture using automatic culture systems. The Bactec 9240 system (Becton Dickinson, Sparks, MD) was used at the Srinagarind University Hospital (Khon Kaen, Thailand), while the BacT/Alert system (Organon Belgie NV, Brussels, Belgium) was used at the Khon Kaen Hospital. The hemoculture fluid (30 ml for Bactec and 40 ml for BacT/Alert) bottles were inoculated with 5 ml of blood specimens and in most cases loaded in the machine within 2 hr of collection. The MAb-LA tests were performed directly on the samples taken from the hemoculture fluids, again within 2 hr after the alarm of the machine sounded (when detectable bacterial growth occurs), which for B. pseudomallei varied between 25 and 30 hr. The hemoculture fluid was simultaneously subcultured in brain heart infusion broth and subjected to conventional biochem- Table 1 . None of the positive hemocultures reacted with the control latex suspension. Of the 120 cases tested with the Bactec 9240 culture system, there were 22 cases with culture proven B. pseudomallei, and the agglutination test result showed a correlation of 100% with the culture result, since neither false-positive nor false-negative results were noted. The BacT/Alert culture system showed that only 4 of 53 cases that were culturepositive for B. pseudomallei failed to agglutinate, and again there were no false-positive results in the remaining 223 cases with other bacterial infections. It should be mentioned that in the latter system, two hemoculture fluids gave weak but definite agglutination results that could be overcome by subculturing in trypticase soy broth for 5-6 hr prior to testing.
The slightly lower sensitivity in the BactT/Alert system could be due to the presence of fewer bacteria when this system was used. We artificially inoculated 100 colonyforming units (CFU) of B. pseudomallei into the culture bottles of both culture systems and found that at the time bacterial growth was detected (17.17 hr for the BacT/Alert compared with 19.11 hr for the Bactec), the concentration of bacteria in the former system was 3.1 ϫ 10 6 CFU/ml while that in the latter was 1.5 ϫ 10 7 CFU/ml. The sensitivity limit for the MAb-LA test when B. pseudomallei were grown in trypticase soy broth was approximately 1-2 ϫ10 6 CFU/ml. In addition to giving a highly satisfactory result comparable with the classical culture method currently used as a gold standard, the combined culture and MAb-LA approach gave a result within 24-30 hr, a significant reduction of the lag time of 3-5 days normally required for the conventional culture and biochemical methods. Most of the time needed for this test involved the growing of enough bacteria to perform the agglutination, which itself required only 1 min. The success of the latex agglutination test described depended upon the amplification of the number of bacteria by hemoculture prior to testing. A similar latex agglutination test based on the use of polyclonal rabbit antiserum was evaluated for detection of B. pseudomallei antigens directly in urine, but the sensitivity was only 18% and 47%, respectively, in unconcentrated and 100-fold concentrated urine. 12 The overall performance of the MAb-LA test was highly satisfactory, with a sensitivity of 95%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 99%. This test was highly specific because there were no false-positive results noted among the 321 hemocultures that showed other microbial growth, including gram-positive (e.g., Staphylococcus, Streptococcus, and Bacillus spp.) and gram-negative (e.g., enteric, Pseudomonas, Burkholderia cepacia, Acinetobacter, and Xanthomonas spp.) bacteria, yeasts, and fungi. Another advantage is that after the incubation for bacterial growth, the additional time required for species identification can be reduced from 1-2 days to only 1 min. This point is very critical in the management of patients with acute septicemia because the earlier the diagnosis is made, the higher the chance of success. It has been reported that about 50% of the patients with septicemic melioidosis die within 48 hr after admission. 5 Based on the data presented, we recommend that this combined method be used in conjunction with the more time-consuming biochemical method so that antibiotic treatment can be initiated as early as possible.
